Purple AI is a South Korean medical AI company that develops brain-disease diagnostic software across the stroke pathway, with AI triage products for intracranial hemorrhage, cerebral infarction and brain aneurysm on CT imaging. Founded in October 2024 as a spin-off from SK AX together with radiology professors from Seoul National University and Ajou University hospitals, it holds US FDA 510(k) clearance and Korea MFDS approval for its flagship hemorrhage-triage product and supplies roughly 40 South Korean general hospitals, with US validation including a 13-site pivotal trial and a research collaboration with Mass General Brigham.
1
Round
1
Industry
5
Tags
Sep 28, 2026
Latest raise
Funding activity · 1 round
Sep 28, 2026
KRW 3.3B
Series A
Led by Murex Partners (뮤렉스파트너스)
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
